Spots Global Cancer Trial Database for fibrolamellar hepatocellular carcinoma (flc)
Every month we try and update this database with for fibrolamellar hepatocellular carcinoma (flc) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma | NCT04248569 | Fibrolamellar H... | DNAJB1-PRKACA p... Nivolumab Ipilimumab | 12 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma | NCT04248569 | Fibrolamellar H... | DNAJB1-PRKACA p... Nivolumab Ipilimumab | 12 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |